MetaCap

Accuray (ARAY) vs Pulsenmore (PLSM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Pulsenmore is the larger company by market cap ($8.4 million vs $6.2 million), about 1.3 times the size. Accuray converts more of its revenue into profit, with a net margin of -12.2% versus -39.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARAY+156.17%PLSM-82.47%
+395%+143%-109%
Jan 21, 20261 yearNov 20, 2026
ARAY+153.05%PLSM-78.21%
+258%+77%-103%
Jan 19, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARAY versus PLSM key metrics
MetricARAYPLSM
Share price$2.08$1.29
Market cap$6.22M$8.39M
1-day change-2.12%-4.44%
YTD return+153.05%—
1-year return+97.62%—
5-year return-59.47%—
EPS (TTM)$-5.60$-1.33
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$401.95M$12.55M
Revenue growth (YoY)-12.34%—
Net income (latest FY)$-49.19M$-4.97M
Gross margin27.73%84.16%
Operating margin-6.58%—
Net margin-12.24%-39.61%
52-week high$45.20$12.97
52-week low$2.05$1.27
Distance from 52-week high-95.41%-90.05%
Analyst consensusnone—
Average volume201.35K49.70K
Shares outstanding3.00M6.50M
Employees80971
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Accuray is more profitable, keeping -12.2 cents of every revenue dollar as net income versus -39.6 cents for Pulsenmore.

About Accuray

ARAY stock →

Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.

Health Care · Medical/Dental Instruments · 809 employees

About Pulsenmore

PLSM stock →

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe.

Health Care · Medical/Dental Instruments · 71 employees

ARAY vs PLSM FAQ

Which is bigger, Accuray or Pulsenmore?

Pulsenmore (PLSM) is larger, with a market capitalization of $8.39M compared with $6.22M for Accuray (ARAY).

Are Accuray and Pulsenmore in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons